Molecular chaperones offer new path to halt Alzheimer's progression

Researchers are exploring molecular chaperones—proteins that repair damaged cells—as a potential treatment for Alzheimer's disease. The approach could reshape dementia care if proven effective in clinical trials, opening a significant market opportunity for biotech companies developing chaperone-based therapies.

Originaltitel: Potential of molecular chaperones for treating Alzheimer's disease